While Upstream Bio Inc has overperformed by 0.12%, investors are advised to look at stock chart patterns for technical insight.
On November 05, 2024, William Blair started tracking Upstream Bio Inc (NASDAQ: UPB) recommending Outperform. A report published by TD Cowen on November 05, 2024, Initiated its previous ‘Buy’ rating for UPB. Piper Sandler also rated UPB shares as ‘Overweight’, setting a target price of $75 on the company’s shares in an initiating report dated November 05, 2024. JP Morgan Initiated an Overweight rating on November 05, 2024, and assigned a price target of $38.
Analysis of Upstream Bio Inc (UPB)
To gain a thorough understanding of Upstream Bio Inc’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. Taking into account the quick ratio of the company, currently set at 20.90, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and UPB is recording an average volume of 396.52K. On a monthly basis, the volatility of the stock is set at 12.18%, whereas on a weekly basis, it is put at 10.37%, with a loss of -1.52% over the past seven days. Furthermore, long-term investors anticipate a median target price of $52.00, showing growth from the present price of $16.19, which can serve as yet another indication of whether UPB is worth investing in or should be passed over.
How Do You Analyze Upstream Bio Inc Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 70.41%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 8.02% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
UPB shares are owned by institutional investors to the tune of 8.02% at present.
